Kunle Odunsi, M.D., Ph.D.
Roswell Park Cancer Institute
Dr. Kunle Odunsi is a professor and research program director in the division of gynecologic oncology, department of surgical oncology and co-leader of the tumor immunology and immunotherapy program at the Roswell Park Cancer Institute. He is also the director of the CRI/LICR Cancer Vaccine Collaborative’s United States operations, and sits on the CRI/LICR Cancer Vaccine Collaborative Coordinated and Review Committee. He is a member of the American Association for Cancer Research, the American Society of Clinical Oncology, American Society for Reproductive Immunology, Association of African Biomedical Scientists, Cooperative Ovarian Cancer Group for Immunotherapy, Gynecologic Oncology Group, Society for Experimental Biology and Medicine, Society for Gynecologic Investigation, and the Society of Gynecologic Oncologists.
Dr. Odunsi earned his medical degree from the University of Ife, Ile-Ife, Nigeria, in 1984, and earned his Ph.D. at the Imperial Cancer Research Fund Laboratories, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, UK. Subsequently, he completed residency training in Obstetrics & Gynecology at the Yale University School of Medicine, New Haven, CT, and clinical fellowship in Gynecologic Oncology at RPCI. He is a Fellow of the Royal College of Obstetricians and Gynaecologists in the United Kingdom. He is also a Fellow of the American College of Obstetricians and Gynecologists. Dr. Odunsi is licensed by New York State and certified in Obstetrics & Gynecology by the American Board of Obstetrics and Gynecology. He is also board certified in the sub-specialty of Gynecologic Oncology.